Risk factors associated with a decrease ≥ 2 g/dL in haemoglobin and/or ≥ 10% haematocrit in osteoarthritis patients taking celecoxib or a nonselective NSAID plus a PPI in a large randomised controlled trial (CONDOR) - Lanas, A; Goldstein, J L; Chan, F K (Aliment Pharmacol Ther, 2012)
et al.